Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Megestrol Acetate in Severe COPD with Weight Loss
NCT00507949Phase 2Completed
- Sponsor
- Rottapharm Biotech
- Start
- Oct 2006
- Primary completion
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in chronic obstructive pulmonary disease (COPD) comparing Megestrol acetate with Placebo (2 arms). Primary endpoint: Body weight at 8 weeks. Started Oct 2006; status: completed.
02
Drugs
megestrol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00507949.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00507949.